Swedish Cancer Foundation   Report issue

Foundation Phase 3 Phase 4
Founded: Seattle WA United States (1951)

Organization Overview

First Clinical Trial
2000
NCT00329615
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Swedish Cancer Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Cachexia (Phase 4)

Wasting Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 8